Remove 2004 Remove Clinical Trials Remove Sleep
article thumbnail

How Cannabis Research is Affecting Parkinson’s Disease

The Joint Blog

The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial would be used to assess whether or not CBD could treat the psychosis symptoms of Parkinson’s. This trial was to take 3.5 However, they also stated that there have been promising effects noted in lab studies.

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. military officers at the National Defense University in Washington DC from 2004 till 2010. ” Underground researcher.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis for IBS: Treating Irritable Bowel Syndrome with Medical Marijuana

Greencamp

Constant gut symptoms often lead to the development of other conditions like anxiety , depression , migraines , sleeping problems and fatigue. Cannabis research still has a long way to go regarding this topic, and it will take more clinical trials to fully understand how cannabis helps with IBS. What causes IBS?

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

The ECS plays an important role in managing numerous processes, ranging from sleep, mood, immune functions, metabolism, movement and pain. Also presented in the American Journal of Hospice and Palliative Care, a 2004 survey set about to discover the effect of cannabis use on ALS in humans. 16: Cannabis; June 2012, Pages 400-404.

Strains 94
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

The ECS touches on nearly every biological function you have, including sleep, pain, appetite, body temperature, immune function, memory, and hormone regulation. 4 A 2004 study found that the endocannabinoid anandamide can inhibit trigeminal neurons, which suggests a way in which endocannabinoids may be able to prevent migraines.

Terpenes 135
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Conditions most frequently mentioned. Full size image. Headline and article tone.